This rabbit polyclonal antibody  was generated against a synthetic peptide corresponding to residues 25-41 (SGPKPLFRRMSSLVGPT) of human CD20 conjugated to ovalbumin, and is specific for the intracellular N-terminal region of human CD20.
CD20, or B-lymphocyte antigen CD20, is a cell-surface protein expressed in most immune cells arising from the B-cell lineage and plays a role in cellular activation and proliferation. Importantly, CD20 is a recognized biomarker for a number of human disorders, including several autoimmune diseases and B-cell malignancies.
From the laboratory of Julie P. Deans, PhD, University of Calgary.
Part of The Investigator's Annexe program.
|Molecular Weight:||33-35 kDa|
|Immunogen:||Peptide conjugated to ovalbumin|
|Epitope:||N-terminal residues 25-41; SGPKPLFRRMSSLVGPT|
|Tested Applications:||WB (1:10,000), IP|
Western Blot of CD20 N and C-terminus
Western blots of human Ramos B-cells lysates probed with rabbit anti-CD20N (targeting the N-terminal residues 25-41) and rabbit anti-CD20C (targeting the C-terminal residues 231-245), pre-incubated with immunizing peptide (lanes 2 and 5), irrelevant peptide (lanes 3 and 6) or no peptide (lanes 1 and 4).
Adapted from: Polyak MJ, et al. J Immunol. 1998 Oct 1;161(7):3242-8.
If you publish research with this product, please let us know so we can cite your paper.